The positive correlation between DJ-1 and β-catenin expression shows prognostic value for patients with glioma

Neuropathology

Volumn 33, Issue 6, 2013, Pages 628-636

  Wang, Chao ^a   Fang, Mao ^b   Zhang, Meng ^c   Li, Weiping ^c   Guan, Hong ^c   Sun, Yanhua ^c   Xie, Siming ^a   Zhong, Xueyun ^a  

^a UNIVERSITY OF JINAN   (China)

^b GUANGZHOU MEDICAL UNIVERSITY   (China)

^c SECOND PEOPLE S HOSPITAL OF SHENZHEN   (China)

Author keywords

DJ 1; Glioma; P Akt; PTEN; catenin

Indexed keywords

BETA CATENIN; DJ 1 PROTEIN; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN KINASE B; SMALL INTERFERING RNA;

ADULT; ARTICLE; CANCER GRADING; CANCER PROGNOSIS; CANCER SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; GENE SILENCING; GLIOBLASTOMA; GLIOMA; GLIOMA CELL; HUMAN; HUMAN CELL CULTURE; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; MAJOR CLINICAL STUDY; MALE; NULL CELL; OVERALL SURVIVAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REDUCTION; SURVIVAL TIME; TUMOR CELL CULTURE; TUMOR GROWTH; TUMOR RECURRENCE; WESTERN BLOTTING; WILD TYPE;

DJ-1; GLIOMA; P-AKT; PTEN; Β-CATENIN;

ADOLESCENT; ADULT; AGED; BETA CATENIN; BLOTTING, WESTERN; BRAIN NEOPLASMS; CHILD; CHILD, PRESCHOOL; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; GLIOMA; HUMANS; IMMUNOHISTOCHEMISTRY; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; NEOPLASM GRADING; ONCOGENE PROTEINS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROTO-ONCOGENE PROTEINS C-AKT; PTEN PHOSPHOHYDROLASE; RNA, SMALL INTERFERING; TRANSFECTION; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 84897076129     PISSN: 09196544     EISSN: 14401789     Source Type: Journal    
DOI: 10.1111/neup.12041     Document Type: Article

References (36)

1. Schwartzbaum JA, Fisher JL, Aldape KD, Wrensch M. Epidemiology and molecular pathology of glioma. Nat Clin Pract Neurol 2006; 2: 494-503. 1-516.
2. Central brain tumor registry of the United States. [Cited 4 April 2013.] Available from URL: http://www.CBTRUS.org
3. See SJ, Gilbert MR. Anaplastic astrocytoma: diagnosis, prognosis, and management. Semin Oncol 2004; 31: 618-634.
4. Butowski NA, Sneed PK, Chang SM. Diagnosis and treatment of recurrent high-grade astrocytoma. J Clin Oncol 2006; 24: 1273-1280.
5. Komotar RJ, Mocco J, Jones JE etal. Pilomyxoid astrocytoma: diagnosis, prognosis, and management. Neurosurg Focus 2005; 18: E7.
6. Ohgaki H, Dessen P, Jourde B etal. Genetic pathways to glioblastoma: a population-based study. Cancer Res 2004; 64: 6892-6899.
7. Sano T, Lin H, Chen X etal. Differential expression of MMAC/PTEN in glioblastoma multiforme: relationship to localization and prognosis. Cancer Res 1999; 59: 1820-1824.
8. Nagakubo D, Taira T, Kitaura H etal. DJ-1, a novel oncogene which transforms mouse NIH3T3 cells in cooperation with ras. Biochem Biophys Res Commun 1997; 231: 509-513.
9. Kim RH, Peters M, Jang Y etal. DJ-1, a novel regulator of the tumor suppressor PTEN. Cancer Cell 2005; 7: 263-273.
10. MacKeigan JP, Clements CM, Lich JD, Pope RM, Hod Y, Ting JP. Proteomic profiling drug-induced apoptosis in non-small cell lung carcinoma: identification of RS/DJ-1 and RhoGDIalpha. Cancer Res 2003; 63: 6928-6934.
11. Le Naour F, Misek DE, Krause MC etal. Proteomics-based identification of RS/DJ-1 as a novel circulating tumor antigen in breast cancer. Clin Cancer Res 2001; 7: 3328-3335.
12. Korkaya H, Paulson A, Charafe-Jauffret E etal. Regulation of mammary stem/progenitor cells by PTEN/Akt/beta-catenin signaling. PLoS Biol 2009; 7: e1000121.
13. Persad S, Troussard AA, McPhee TR, Mulholland DJ, Dedhar S. Tumor suppressor PTEN inhibits nuclear accumulation of beta-catenin and T cell/lymphoid enhancer factor 1-mediated transcriptional activation. J Cell Biol 2001; 153: 1161-1174.
14. Sparks AB, Morin PJ, Vogelstein B, Kinzler KW. Mutational analysis of the APC/beta-catenin/Tcf pathway in colorectal cancer. Cancer Res 1998; 58: 1130-1134.
15. Robbins PF, El-Gamil M, Li YF etal. A mutated beta-catenin gene encodes a melanoma-specific antigen recognized by tumor infiltrating lymphocytes. J Exp Med 1996; 183: 1185-1192.
16. Voeller HJ, Truica CI, Gelmann EP. Beta-catenin mutations in human prostate cancer. Cancer Res 1998; 58: 2520-2523.
17. Miyoshi Y, Iwao K, Nagasawa Y etal. Activation of the beta-catenin gene in primary hepatocellular carcinomas by somatic alterations involving exon 3. Cancer Res 1998; 58: 2524-2527.
18. Chan EF, Gat U, McNiff JM, Fuchs E. A common human skin tumour is caused by activating mutations in beta-catenin. Nat Genet 1999; 21: 410-413.
19. Jamieson CH, Ailles LE, Dylla SJ etal. Granulocyte-macrophage progenitors as candidate leukemic stem cells in blast-crisis CML. N Engl J Med 2004; 351: 657-667.
20. Situ R, Wang HH, Wang JH, He LP, Zhu XL, Ou WF. Establishement of human brain malignant glioma cell line (SWO-38) and observation of its biologic properties. Chin J Cancer 1987; 4: 235-238.
21. Zhou Y, Li W, Xu Q, Huang Y. Elevated expression of Dickkopf-1 increases the sensitivity of human glioma cell line SHG44 to BCNU. J Exp Clin Cancer Res 2010; 29: 131-137.
22. Kotaria N, Hinz U, Zechel S, von Bohlen UHO. Localization of DJ-1 protein in the murine brain. Cell Tissue Res 2005; 322: 503-507.
23. Lev N, Ickowicz D, Barhum Y, Blondheim N, Melamed E, Offen D. Experimental encephalomyelitis induces changes in DJ-1: implications for oxidative stress in multiple sclerosis. Antioxid Redox Signal 2006; 8: 1987-1995.
24. Rizzu P, Hinkle DA, Zhukareva V etal. DJ-1 colocalizes with tau inclusions: a link between parkinsonism and dementia. Ann Neurol 2004; 55: 113-118.
25. Bandopadhyay R, Kingsbury AE, Cookson MR etal. The expression of DJ-1 (PARK7) in normal human CNS and idiopathic Parkinson's disease. Brain 2004; 127: 420-430.
26. Bonifati V, Rizzu P, van Baren MJ etal. Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism. Science 2003; 299: 256-259.
27. Miyajima Y, Sato Y, Oka H etal. Prognostic significance of nuclear DJ-1 expression in astrocytoma. Anticancer Res 2010; 30: 265-269.
28. Liu X, Wang L, Zhao S, Ji X, Luo Y, Ling F. Beta-Catenin overexpression in malignant glioma and its role in proliferation and apoptosis in glioblastma cells. Med Oncol 2011; 28: 608-614.
29. Utsuki S, Sato Y, Oka H, Tsuchiya B, Suzuki S, Fujii K. Relationship between the expression of E-, N-cadherins and beta-catenin and tumor grade in astrocytomas. J Neurooncol 2002; 57: 187-192.
30. Sareddy GR, Panigrahi M, Challa S, Mahadevan A, Babu PP. Activation of Wnt/beta-catenin/Tcf signaling pathway in human astrocytomas. Neurochem Int 2009; 55: 307-317.
31. Pu P, Zhang Z, Kang C etal. Downregulation of Wnt2 and beta-catenin by siRNA suppresses malignant glioma cell growth. Cancer Gene Ther 2009; 16: 351-361.
32. Ahmad I, Morton JP, Singh LB etal. Beta-Catenin activation synergizes with PTEN loss to cause bladder cancer formation. Oncogene 2011; 30: 178-189.
33. Uegaki K, Kanamori Y, Kigawa J etal. PTEN is involved in the signal transduction pathway of contact inhibition in endometrial cells. Cell Tissue Res 2006; 323: 523-528.
34. Lee H, Choi SK, Ro JY. Overexpression of DJ-1 and HSP90alpha, and loss of PTEN associated with invasive urothelial carcinoma of urinary bladder: possible prognostic markers. Oncol Lett 2012; 3: 507-512.
35. Davidson B, Hadar R, Schlossberg A etal. Expression and clinical role of DJ-1, a negative regulator of PTEN, in ovarian carcinoma. Hum Pathol 2008; 39: 87-95.
36. Hinkle DA, Mullett SJ, Gabris BE, Hamilton RL. DJ-1 expression in glioblastomas shows positive correlation with p53 expression and negative correlation with epidermal growth factor receptor amplification. Neuropathology 2011; 31: 29-37.